New Molecular-Editing Tool CHARM Developed to Combat Prion Diseases
Discover CHARM, a groundbreaking molecular-editing tool designed to combat prion diseases by targeting the gene responsible for harmful protein production. Learn how this innovative system modifies the epigenome to silence disease-causing proteins, offering hope for effective therapeutic intervention. Explore the potential of CHARM in revolutionizing treatment strategies for neurodegenerative disorders like Creutzfeldt-Jakob disease and fatal familial insomnia.
New Biomarker miR-519a-3p Discovered for Asymptomatic Stages of Alzheimer’s Disease
Researchers have discovered a new biomarker, miR-519a-3p, that could be used for early diagnosis and treatment of Alzheimer’s disease in its asymptomatic stages. This microRNA is associated with the cellular prion protein and could enhance diagnostic accuracy in the early stages of the disease. Join our webinar to learn more about the role of organoids in advancing treatment for neurological disorders.